Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PharmaSphere: Asia Pacific Deal Trends, 2004–2013
  • USA - English


News provided by

Research Advisor at Reportbuyer.com

Nov 13, 2013, 12:05 ET

Share this article

Share toX

Share this article

Share toX

London (PRWEB) November 13, 2013 -- PharmaSphere: Asia Pacific Deal Trends, 2004–2013

Summary

GlobalData’s report, "PharmaSphere: Asia Pacific Deal Trends, 2004–2013" offers an in-depth understanding of the key deals that took place in the region during the last decade. The type of deals covered in the report include Mergers & Acquisitions (M&A), Licensing and Collaboration & Partnerships. The report also provides understanding on the regional differences in the deal making activity to that of the global trends and key trends are outlined with insight on drivers such as regulatory policy, macro-economic and industry factors as well as market access challenges. Case studies including the top deals in value among Mergers & Acquisition, Licensing and Collaboration & Partnerships are strategically analyzed to provide comprehensive understanding on areas such as structure and status of the deal vis a vis the overall corporate strategy.

Throughout the report, GlobalData’s analysts provide you with expert insight, expanding on each strategy and factor discussed, with the aim of providing you with the tools you need to make informed business decisions.

Highlights

About the Report

GlobalData’s report, "PharmaSphere: Asia Pacific Deal Trends, 2004–2013” is an essential source of information and analysis on strategic deals in the Asia Pacific region. It includes top players in the global and regional pharmaceuticals and healthcare market. Using detailed company data and financial analysis, GlobalData has highlighted certain deals in the pharmaceutical market, forming a basis for in-depth analysis of the factors driving deal-making in the industry, currently and into the future. The report discusses the key factors shaping and driving the pharmaceutical industry in the Asia Pacific region, and provides insight on the competitive landscape and emerging strategies that are expected to significantly alter the market position of industry leaders.

Key Questions Answered

-How are the main deal categories faring among top countries in the Asia Pacific region over the past decade?
-What are the primary reasons for increased activity in strategic deals by leading pharmaceutical companies in APAC region?
-What are the key trends, and strategies involved in M&As, licensing deals, and collaboration agreements entered into by leading pharmaceutical and healthcare companies in the Asia Pacific region?
-What strategies are the most successful companies pursuing to gain and maintain their market leading position?

Scope

-In-depth understanding of the key pharmaceutical and healthcare deals that took place in the APAC region during the last decade. Furthermore, key deals are discussed from a domestic and global point of view
-Current regulatory framework in various markets in APAC including recent and/or ongoing developments that are expected to impact or influencing the industry are discussed
-Dealmaking strategies: insightful analysis on the terms, strategic implications and synergies of recent deals activity in the APAC pharmaceutical industry
-Collaboration and acquisition strategies: exhaustive discussion on the strategic implications and synergies of recent M&A and partnering activities
-Expert insights on the corporate strategies of various drug companies seeking a competitive advantage in the pharmaceutical market place
-Case studies on top deal making activities shedding light on rationale and strategy.

Reasons to buy

-Understand the primary drivers behind major deal initiatives in the APAC region.
-Analyze the structures of the deal and gain insight on the various factors considered when structuring deal terms in strategic acquisitions, mergers, collaborations, and licensing.
-Identify rationale behind potential takeover targets and partners, thereby maximizing your opportunities for consolidation, investment, and strategic partnerships in the Asia Pacific region.
-Use this information as an independent source for your due diligence and transaction strategy.

Table of Contents

1 Table of Contents 7
1.1 List of Tables 10
1.2 List of Figures 11
2 Introduction 12
2.1 Report Scope 12
2.1.1 Key Questions Answered 12
2.1.2 Key Benefits 13
2.2 Upcoming Related Reports 13
3 Historical Dealmaking Trends 14
3.1 Overview 14
3.2 Leading Deal Drivers 15
3.2.1 Rising Drug Marketing Barriers in Western Developed Economies 15
3.2.2 Generic Competition and the Patent Cliff 15
3.2.3 Move Towards Universal Healthcare Access and Health Insurance Expansion 17
3.2.4 Increasing Consolidation 18
3.3 Overall Deals in Review 19
3.3.1 Review by Deal Type 19
4 Mergers and Acquisitions 23
4.1 Overview 23
4.2 Case Studies 27
4.2.1 Takeda Pharmaceutical Acquires Nycomed 27
4.2.2 Takeda Pharmaceutical Acquires US Firm Millennium Pharmaceuticals 28
4.2.3 Daiichi Pharmaceutical Merges with Sankyo Pharma 29
4.2.4 Yamanouchi Pharmaceutical Merges with Fujisawa Pharmaceutical to Form Astellas Pharma 31
4.2.5 Daiichi Sankyo Acquires India’s Ranbaxy Laboratories 32
4.2.6 Khazanah Nasional Acquires Majority Stake in Parkway Holdings 34
4.2.7 Primary Health Care Acquires Symbion Health 35
4.2.8 Teva Pharmaceutical Industries Acquires Taiyo Pharmaceutical Industry 36
5 Licensing Arrangements 38
5.1 Overview 38
5.2 Case Studies 41
5.2.1 Lundbeck and Otsuka Pharmaceutical Collaborate on Five CNS Drugs 41
5.2.2 Astellas Pharma Enters into Licensing Agreement with AVEO Pharmaceuticals for Tivozanib 42
5.2.3 Takeda Pharmaceutical Enters into Collaboration Agreement with Alnylam Pharmaceuticals 44
5.2.4 Amylin Pharmaceuticals Enters into Licensing Agreement with Takeda Pharmaceutical 45
5.2.5 Janssen Biotech Enters into Licensing Agreement with Astellas Pharma for ASP015K 47
6 Collaborations and Partnerships 49
6.1 Overview 49
6.2 Case Studies 52
6.2.1 Amgen Enters into Co-Development Agreement with Takeda Pharmaceutical 52
6.2.2 Medivation Enters into Co-Development Agreement with Astellas Pharma 54
6.2.3 S*BIO Enters into Co-Development Agreement with Onyx Pharmaceuticals 56
6.2.4 Takeda Pharmaceutical Enters into Agreement with Affymax 58
6.2.5 Ambit Biosciences Corporation Enters into Co-Development Agreement with Astellas Pharma 59
7 Future Outlook 61
7.1 Overview 61
7.2 Deal-Making Trends 61
7.2.1 Licensing Deals to Increase as a Key Source of Pipeline Growth for Big Pharma and Biotech Firms in the APAC Region 61
7.2.2 Acquisitions and Alliances to Expand Geographical Footprint 62
7.2.3 Key Challenges Include Economic Climate, Regulation, Intellectual Property, and Volume-Based Generics Market 63
8 Appendix 65
8.1 Bibliography 65
8.2 Abbreviations 65
8.3 About the Author 68
8.3.1 Aparna Krishnan, Industry Analyst 68
8.4 Director, Healthcare Industry Dynamics 68
8.5 Global Head of Healthcare 69
8.6 About the Industry Dynamics Team 70
8.7 About GlobalData 70
8.8 Disclaimer 70

List of Tables

Table 1: Top-Selling Drugs with Recent and Upcoming US Patent Expirations 16
Table 2: Top 20 M&A Deals by Value, APAC Region, 2004–2013 24
Table 3: Takeda Pharmaceutical Acquires Nycomed 27
Table 4: Takeda Pharmaceutical Acquires Millenium Pharmaceuticals 28
Table 5: Daiichi Pharmaceutical Merges with Sankyo Pharma 29
Table 6: Yamanouchi Pharmaceutical Merges With Fujisawa Pharmaceutical 31
Table 7: Daiichi Sankyo Acquires Ranbaxy Laboratories 32
Table 8: Khazanah Nasional Acquires Majority Stake in Parkway Holdings 34
Table 9: Primary Health Care Acquires Symbion Health 35
Table 10: Teva Pharmaceutical Industries Acquires Taiyo Pharmaceutical Industry 36
Table 11: Top 20 Licensing Deals, APAC Region, 2004–2013 39
Table 12: Lundbeck and Otsuka Pharmaceutical Enter Into Drug Development Collaboration 41
Table 13: Astellas Pharma’s Licensing Deal with AVEO Pharmaceuticals 42
Table 14: Takeda Pharmaceutical Enters into Collaboration Agreement with Alnylam Pharmaceuticals 44
Table 15: Amylin Pharmaceuticals Enters into Licensing Agreement with Takeda Pharmaceutical 45
Table 16: Janssen Biotech Enters into Licensing Agreement with Astellas Pharma 47
Table 17: Top 20 Partnership Deals in the APAC Region, 2004–2013 50
Table 18: Amgen Enters into Co-Development Agreement with Takeda for 13 Drugs 52
Table 19: Medivation Enters into Co-Development Agreement with Astellas Pharma for Prostate Cancer Drug 54
Table 20: S*BIO Enters into Co-Development Agreement with Onyx Pharmaceuticals 56
Table 21: Takeda Pharmaceutical Enters into Agreement with Affymax for Anemia Drug 58
Table 22: Ambit Biosciences Corporation Enters into Co-Development Agreement with Astellas Pharma 59

List of Figures

Figure 1: Number of M&A Deals, APAC Region, 2004–2013 19
Figure 2: Number of Drug Discovery M&A Deals, APAC Region, 2004–2013 20
Figure 3: Number of Licensing Deals, APAC Region, 2004–2013 21
Figure 4: Collaboration and Partnership Deals, APAC Region, 2004–2013 22
Figure 5: Top Five Spenders on M&A Activities ($m), APAC Region, 2004–2013 25
Figure 6: Number of M&A Deals per Country, APAC Region, 2004–2013 26
Figure 7: Upfront and Milestone Payments in the Top 20 Licensing Deals, APAC Region, 2004–2013 40

Read the full report:

PharmaSphere: Asia Pacific Deal Trends, 2004–2013

http://www.reportbuyer.com/pharma_healthcare/general_industry/pharmasphere_asia_pacific_deal_trends_2004_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.